James Edgemond is CFO & Treasurer at UNITED THERAPEUTICS Corp (UTHR). They have made 1 open-market trade across 1 company since 2024, most recently 2026-06-22.
CIK 0001636178
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 18,876 | $10.1M |
Shares reported on the most recent Form 4, priced at the 2026-06-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-06-22 | 2026-06-23 | $538.15 | $4.7M | +0.4% | -2.9% | -9.5% |
| UTHR | SELL · 10b5-1 | 2026-06-18 | 2026-06-22 | $540.15 | $5.4M | +2.5% | -2.8% | -9.0% |
| UTHR | SELL · 10b5-1 | 2026-06-15 | 2026-06-16 | $549.17 | $5.5M | -1.3% | -4.2% | -8.9% |
| UTHR | SELL · 10b5-1 | 2026-06-11 | 2026-06-12 | $549.29 | $5.5M | +0.1% | -1.4% | -7.2% |
| UTHR | SELL · 10b5-1 | 2026-06-08 | 2026-06-09 | $547.50 | $5.5M | -2.7% | -0.2% | -9.9% |
| UTHR | SELL · 10b5-1 | 2026-06-04 | 2026-06-05 | $546.28 | $5.5M | +0.4% | -0.3% | -10.8% |
| UTHR | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $547.87 | $5.5M | +0.9% | +2.7% | -5.6% |
| UTHR | SELL · 10b5-1 | 2026-05-28 | 2026-05-29 | $565.63 | $5.7M | -1.5% | -1.5% | -4.5% |
| UTHR | SELL · 10b5-1 | 2026-05-26 | 2026-05-27 | $572.94 | $5.7M | -4.6% | -5.1% | -9.2% |
| UTHR | SELL · 10b5-1 | 2026-05-21 | 2026-05-22 | $564.11 | $5.6M | -3.4% | -5.1% | -8.1% |
| UTHR | SELL · 10b5-1 | 2026-05-18 | 2026-05-19 | $567.31 | $5.7M | -4.7% | -6.1% | -11.1% |
| UTHR | SELL · 10b5-1 | 2026-05-14 | 2026-05-15 | $574.47 | $5.7M | -0.9% | -3.2% | -11.5% |
| UTHR | SELL · 10b5-1 | 2026-05-11 | 2026-05-12 | $573.03 | $5.7M | -1.9% | -5.9% | -8.6% |
| UTHR | SELL · 10b5-1 | 2026-05-07 | 2026-05-11 | $578.58 | $5.8M | -0.9% | -4.6% | -7.3% |
| UTHR | SELL · 10b5-1 | 2026-05-04 | 2026-05-05 | $576.93 | $5.8M | -4.1% | -7.6% | -12.9% |
| UTHR | SELL · 10b5-1 | 2026-04-30 | 2026-05-01 | $572.61 | $5.7M | +2.1% | -3.9% | -7.2% |
| UTHR | SELL · 10b5-1 | 2026-04-27 | 2026-04-28 | $568.83 | $5.7M | -0.3% | -0.8% | -7.0% |
| UTHR | SELL · 10b5-1 | 2026-04-22 | 2026-04-24 | $572.34 | $5.7M | +5.2% | +2.0% | -6.7% |
| UTHR | SELL · 10b5-1 | 2026-04-20 | 2026-04-21 | $577.86 | $5.8M | -0.6% | -1.4% | -7.7% |
| UTHR | SELL · 10b5-1 | 2026-04-16 | 2026-04-17 | $577.18 | $5.8M | -3.8% | -4.5% | -10.9% |
| UTHR | SELL · 10b5-1 | 2026-04-13 | 2026-04-14 | $574.88 | $5.7M | -2.4% | -1.2% | -7.9% |
| UTHR | SELL · 10b5-1 | 2026-04-09 | 2026-04-10 | $577.89 | $5.8M | +0.5% | -0.2% | -3.4% |
| UTHR | SELL · 10b5-1 | 2026-04-06 | 2026-04-07 | $558.40 | $5.6M | +2.9% | -0.4% | -4.3% |
| UTHR | SELL · 10b5-1 | 2026-04-02 | 2026-04-06 | $561.50 | $5.6M | +3.1% | +6.0% | -2.7% |
| UTHR | SELL · 10b5-1 | 2026-03-30 | 2026-03-31 | $592.72 | $11.3M | -3.2% | -4.2% | -8.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.